Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
Published on: July 28, 2023
Why internists should care about Helicobacter pylori: recapitulating gastric cancer prevention
Agostino Di Ciaula1, Mohamad Khalil2, Giulia Fiorini3
1Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), Clinica Medica "A. Murri", University of Bari "Aldo Moro" Medical School, Piazza Giulio Cesare 11, 70124, Bari, Italy. agodiciaula@gmail.com.
Abstract:
Infection with Helicobacter pylori (H. pylori) is a leading but also modifiable cause of gastric cancer. However, evidence indicates that the goal of a primary prevention of gastric cancer is still far from being achieved. Main obstacles derive from inadequate screening and management of H. pylori infection but also from other external risk factors, responsible for about a quarter of future cases of gastric cancer. The need for population-based H. pylori screen-and-treat programs remains not fully addressed, mainly due to concerns about cost, to underpowered screening efficacy of policies only targeting symptomatic people, to the lack of screen-and-treat approach performed early. Further concerns derive from persisting gaps between guideline-recommended H. pylori management and real-world patterns, leading to inappropriate therapies and increased antimicrobial resistance. A critical role is also played by unhealthy lifestyle and by environmental factors other than H. pylori. In fact, critical external factors increasing the risk of gastric cancer originate from the contamination of environmental matrices and of the food chain with toxic chemicals of anthropogenic origin. An effective strategy for the primary prevention of gastric cancer should therefore consider a full implementation of population-based screen-and-treat programs, but also educational strategies oriented to correct unhealthy habits, and rules and policies oriented to decrease the involuntary exposure to toxic chemicals. In the absence of this comprehensive approach and urgent and efficient prevention policies, local health systems should be prepared to manage the high cost deriving from the growing burden of a preventable (but not prevented) disease, as is gastric cancer. Maximal efforts should also be oriented to ensure a correct application of the available guidelines for the management of H. pylori infection. This goal should lead to an accurate selection of the best treatment regimen, but also to antibiotic stewardship, and to constant monitoring of outcomes and epidemiologic data, to improve quality and equity of care. Internist as well urge to master such topics which involve present and future key public health issues.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease